Amedisys (AMED) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- FedEx pilots ratify new collective bargaining agreement
- The real reason Meta shares are surging has nothing to do with its new AI model
- JPMorgan analysts name top short ideas for third quarter 2026
Amedisys Reports Second Quarter 2021 Financial Results, Closing of Contessa Acquisition, Expansion of Credit Facility and Authorization of New $100 Million Share Repurchase Program
August 4, 2021 4:05 PM EDTBATON ROUGE, La., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2021.
Three-Month Periods Ended June 30, 2021 and 2020
Net service revenue increased $79.2Â million to $564.2Â million compared to $485.0Â million in 2020.Net income attributable to Amedisys, Inc. of $80.1Â million compared to $34.7Â million in 2020.Net income attributable to Amedisys, Inc. per diluted share of $2.43 compared to $1.04 in 2020.Adjusted Quarterly Results*
Adjusted EBITDA of $83.8Â million compared to $66.4Â million in 2020.Adjusted net service revenue of $557.6Â million compared to $485.0Â million in... More